This disclosure presents systems and methods for
baroreflex activation therapy (BAT) to regulate
inflammation by modulating
autonomic nervous system activity. Electrical stimulation is delivered to one or more baroreceptors, and real-time physiological signals are monitored, including inflammatory biomarkers (e.g., TNF-α, IFN-γ, IL-1, IL-6, IL-12, CRP) and autonomic parameters such as
heart rate variability (HRV). A closed-loop feedback module analyzes biomarker fluctuations and autonomic balance changes and dynamically modifies stimulation parameters, including amplitude, pulse width, frequency, and
duty cycle, to suppress
systemic inflammation and restore autonomic balance. In certain embodiments, multi-channel stimulation architectures and AI-driven algorithms or
machine learning models analyze biomarker trends and historical
patient response patterns to optimize therapy. The disclosed BAT systems and methods may be used to treat inflammatory diseases, autoimmune disorders,
cancer progression, chronic
inflammatory pain conditions, arrhythmias associated with
inflammation, and metabolic dysfunction.